Clinical Trial Update: The ATLAST Long-Term Study [Phase 2, Phase 3]

View source ↗

Summary

The ATLAST Long-Term Study, a Phase 2/3 trial sponsored by ApniCure, Inc., for Obstructive Sleep Apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• ApniCure Investigational Therapy

Snippet

Sponsor: ApniCure, Inc. | Conditions: Obstructive Sleep Apnea (OSA) | Phase 2, Phase 3 | Status: COMPLETED